World Health Organization
Avenue Appia 20
1211
Geneva 27
Tel: 00-41-22-791-21-11
Fax: +00-41-22-791-3111
Website: http://www.who.int/
Email: info@who.int
408 articles with World Health Organization
-
Oramed Pharmaceuticals said that its majority-owned firm Oravax Medical would be spearheading the project, first in Israel and later in other international clinical locations.
-
COVID-19: Vaccines vs. Delta Variant, CDC Predicts Rising Death Toll in Unvaccinated and More
7/22/2021
As COVID-19 begins yet another surge across the U.S., there is some promising news about the effectiveness of vaccines. Here’s a look at some top COVID-19 stories. -
WHO Investigators have attempted to return to the Wuhan lab to find the origins of the novel coronavirus but are now being blocked by the Chinese government.
-
The lawsuit alleges that Ocugen made “materially false and misleading statements” about its operations and compliance policies.
-
Moderna CEO Stéphane Bancel believes the promise of mRNA vaccines is so great they will become a disruptive force in preventing viral infections.
-
The data may show the need for one, but vaccine and immunologists are pushing back against Pfizer and BioNTech’s contention that one is necessary now.
-
The U.S. appears to be beating back COVID-19 but it’s still raging in many parts of the world, and studies and trials are still ongoing. Here’s a look at some of today’s top COVID-19 stories.
-
The WHO panel recommends adopting global standards, giving structure to prevent the unscrupulous, inequitable, and possibly dangerous uses of CRISPR technology.
-
Ivermectin has become a contentious issue as to whether it effectively prevents and treats COVID-19. Several studies suggest it is effective, while others have indicated it is not.
-
The WHO is calling for manufacturers to cut prices and increase the availability of supplies to low- and middle-income nations to parts of the world where COVID-19 continues to surge.
-
Continuing studies and news about COVID-19 around the world keeps coming in. Here’s a look.
-
Female-Founded Antheia Raises $73 Million to Support Synthetic Biology for Essential Medicines
6/30/2021
Christina Smolke said the financing will enable the company to use its synthetic biology platform to support essential medications that rely on plant-based materials. -
New data continues to emerge that seems to add to the possibility of COVID-19 originating from a lab leak at China’s Wuhan Institute of Virology.
-
The analysis showed that the Pfizer and Oxford/AstraZeneca vaccines can protect patients from being hospitalized by as much as 90 percent.
-
New data shows Zolgensma, Novartis’ gene therapy for spinal muscular atrophy, has the potential to be used presymptomatically in juveniles.
-
Performance Update on World Health Organisation SARS-CoV2 Serology Standards
6/15/2021
MedMira Inc. announces the World Health Organization SARS-CoV-2 serology standards testing results.
-
While several countries rely on Sinovac Biotech to end the pandemic, concerns regarding the shot’s efficacy continue to shroud the vaccine. Currently, it is the second most used vaccine worldwide.
-
The latest news in COVID-19 includes support for an investigation into the origins of the virus, a new naming system, and legal discussions of whether employers can mandate vaccination.
-
The White House has also called for an independent investigation and more information from China about the pandemic's origins.
-
The Francis Crick Institute and the Latvian Institute of Organic Synthesis developed a new compound that blocks the life cycle of the mosquito-borne parasite that causes malaria.